Fundraising Fox

Medical Devices Series C Investors & VC Firms

439 firms in this list, with a median first check of $1M. 92 of them lead rounds. Generated from verified public data and updated continuously.

BioFrontier Partners, Inc.
TokyoSeries A–Late Stage$500K – $3M
11 people
Med-Fine Capital
ShanghaiSeed–Late Stage
8 people
Saisei Ventures
CambridgePre-Seed–Growth
8 people
Montis Capital
WarsawSeries A–Growth$1.6M – $5.5M
2 people
CapMan
HelsinkiSeries A–Late Stage$2.2M – $64.8M
Gore Range Capital
SouthlakeSeed–Late Stage$500K – $5M
3 people
SPRINT Accelerator
MoscowPre-Seed–Growth
Alibaba Entrepreneurs Fund
Hong KongSeed–Late Stage$1.2M – $150M
2 people
Radar Ventures
Pre-Seed–Growth
1 person
Axil Capital
TokyoSeed–Late Stage
7 people
ACORN BIOVENTURES
New YorkSeed–Late Stage
3 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Growth$16.2M
7 people
DCI Partners Co. Ltd.
TokyoPre-Seed–Growth$4.3M – $71M
4 people
University Associates Venture Capital
TucsonSeed–Growth
4 people
Muirwoods Ventures
SeoulSeed–Late Stage
Redhills Ventures LLC
Las VegasSeed–Late Stage$125K – $7M
3 people
Mizuho Capital
TokyoPre-Seed–Late Stage$1.5M – $340M
1 person
Agility Capital
Santa BarbaraSeries C–Late Stage$250K – $1.5M
4 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
4 people
Champel Capital
JerusalemSeed–Late Stage
6 people
dsm-firmenich Venturing
MaastrichtPre-Seed–Late Stage$108K – $5.4M
9 people
OTV
New YorkSeries C–Late Stage
Cathay Health
San FranciscoSeed–Late Stage
5 people
SBI Investment Korea Co. Ltd.
SeoulSeed–Late Stage$2.5M – $33M

Related lists

Data sourced from public filings and firms' own websites — see our methodology.